Anglo Celtic Cooperative Oncology Group Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2001
NCT00017095
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 4)

Infertility (Phase 3)

Inflammatory Breast Neoplasms (Phase 3)

Neutropenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8